— Know what they know.
Not Investment Advice

THCT OTC

THC Therapeutics, Inc.
1W: -50.0% 1M: -50.0% 3M: -66.7% YTD: +200.0% 1Y: -40.0% 3Y: +1300.0% 5Y: -80.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 44 · $11660 mcap · 30M float · 0.0014% daily turnover · Short 62% of daily vol

Cash Flow Trends

Operating Cash Flow
-$85K +79.6% ▲
Capital Expenditures
$0 +100.0% ▲
Free Cash Flow
-$85K +79.6% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +100.0% ▲
Net Change in Cash
-$22 +100.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
— Operating Activities —
Net Income-$23M-$2M-$2M-$2M-$387K
Depreciation & Amort.$26K$20K$16K$12K$1K
Stock-Based Comp.$24M$438K$116K$837K$87K
Change in Working Capital$227K$358K$513K$564K$399K
Other Non-Cash Items-$8M$426K$458K-$313K$170K
Operating Cash Flow-$330K-$588K-$388K-$419K-$85K
— Investing Activities —
Capital Expenditures-$1K$0$0$0$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0-$153K$0$0
Investment Sales$0$0$0$0$0
Other Investing-$1K$0$0$0$0
Investing Cash Flow-$1K$0-$153K$0$0
— Financing Activities —
Net Debt Issuance$646K$314K-$12K$25K-$15K
Stock Repurchased$0$0$0-$98K$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$48K$0
Financing Cash Flow$646K$314K$794K$123K$85K
Net Change in Cash$315K-$274K$253K-$296K-$22
Cash End of Period$318K$43K$296K$32$10
Free Cash Flow-$331K-$588K-$388K-$419K-$85K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms